Skip to content

Clinical trials

Phase 2 Testicular Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Testicular Neoplasms Phase: Phase 2 Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20022
20032
20046
20053
20064
20074
20083
20093
20103
20134
20151
20163
20172
20182
20191
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Terminated10
Recruiting4
Unknown status3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center8
Fred Hutchinson Cancer Center6
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano4
National Cancer Institute (NCI)4
Children's Oncology Group2
City of Hope Medical Center2
European Organisation for Research and Treatment of Cancer - EORTC2
Masonic Cancer Center, University of Minnesota2
Medical Research Council2
National Cancer Institute, Slovakia2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Testicular Neoplasms68
Ovarian Neoplasms22
Teratoma18
Carcinoma, Embryonal15
Neoplasms, Germ Cell and Embryonal15
Seminoma14
Breast Neoplasms13
Burkitt Lymphoma13
Endodermal Sinus Tumor13
Neuroblastoma13

Trials

Showing 76 to 68 of 68. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.